The role of allogeneic hematopoietic stem cell transplantation in adults with mature T-cell lymphomas.
A rigorous review clarifies when stem cell transplantation may help adults with rare, aggressive T-cell lymphomas where treatment options are extremely limited.
This Cochrane review synthesizes evidence on allogeneic stem cell transplantation in adults with mature T-cell lymphomas—a heterogeneous group with high unmet need and limited treatment evidence. It provides the most current evidence base to guide treatment decision-making in this challenging malignancy.
What the study was
- Study design
- Cochrane systematic review and meta-analysis of randomized and observational evidence for allo-HSCT in mature T-cell lymphomas
- Population
- Adults with mature T-cell lymphomas
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Cochrane Database of Systematic Reviews
Why it surfaced
Cochrane systematic review (highest design quality for evidence synthesis) on allo-HSCT in mature T-cell lymphomas; sentinel scan find that matches hematologic malignancy watchlist topic.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.